LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

被引:10
|
作者
Leng, Shusheng [1 ,2 ,3 ]
Xie, Fei [4 ]
Liu, Junyi [5 ]
Shen, Junyi [1 ,2 ]
Quan, Guangqian [1 ,2 ]
Wen, Tianfu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Gen Surg Dept, Chengdu, Peoples R China
[4] First Peoples Hosp Neijiang City, Dept Hepatobiliary Pancreat & Splen Surg, Neijiang, Peoples R China
[5] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Cent Lab, Chengdu, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LLGL2; Hepatocellular Carcinoma; PI3K; AKT signaling; Calcium influx; Progression; HUMAN HOMOLOG; DROSOPHILA; LGL; HUGL-1; POLARITY; EXPRESSION; MORPHOGENESIS; DIVISION; CLONING; GROWTH;
D O I
10.3389/fonc.2021.683629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. Methods TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. Results LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. Conclusion Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
    Yang, Yu-Feng
    Zhang, Mei-Fang
    Tian, Qiu-Hong
    Fu, Jia
    Yang, Xia
    Zhang, Chris Zhiyi
    Yang, Hong
    MOLECULAR CANCER, 2018, 17
  • [2] SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
    Yu-Feng Yang
    Mei-Fang Zhang
    Qiu-Hong Tian
    Jia Fu
    Xia Yang
    Chris Zhiyi Zhang
    Hong Yang
    Molecular Cancer, 17
  • [3] TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway
    Huang, Dan-Hong
    Jian, Jie
    Li, Shuang
    Zhang, Yan
    Liu, Li-Zhen
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (06) : 2113 - 2122
  • [4] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [5] Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway
    Hua, Hui
    Zhu, Yu
    Song, Yu-He
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 115 - 122
  • [6] Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway
    Liu, Xin
    Hu, Yi
    Li, Cairong
    Chen, Jiayu
    Liu, Xiaohong
    Shen, Yang
    Xu, Yangtao
    Chen, Wenliang
    Xu, Ximing
    CANCERS, 2023, 15 (06)
  • [7] Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
    Liao, Junbin
    Jin, Huilin
    Li, Shaoqiang
    Xu, Lixia
    Peng, Zhenwei
    Wei, Guangyan
    Long, Jianting
    Guo, Yu
    Kuang, Ming
    Zhou, Qi
    Peng, Sui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (01)
  • [8] Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
    Huang, Lu
    Yang, Qiong
    Chen, Huihong
    Wang, Zhenggeng
    Liu, Qi
    Ai, Shuhua
    OPEN MEDICINE, 2022, 17 (01): : 626 - 637
  • [9] Dantrolene Potentiates the Antineoplastic Effect of Sorafenib in Hepatocellular Carcinoma via Targeting Ca+2/PI3K Signaling Pathway
    Zakaria, Sherin
    Ansary, Abeer
    Abdel-Hamid, Nabil M.
    ElShishtawy, Mamdouh M.
    CURRENT MOLECULAR PHARMACOLOGY, 2021, 14 (05) : 900 - 913
  • [10] ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
    Ni, Sheng
    Wei, Qian
    Yang, Li
    ONCOTARGETS AND THERAPY, 2020, 13 : 12409 - 12419